LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW)

CUSIP: G9845F117

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / *W EXP 03/15/202
Total 13F shares
6,385,283
Share change
-125,300
Total reported value
$301,751
Price per share
$0.05
Number of holders
29
Value change
-$327,360
Number of buys
4
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP G9845F117?
CUSIP G9845F117 identifies LSBPW - LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW) as of Q2 2023

As of 30 Jun 2023, LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,385,283 shares. The largest 10 holders included LMR Partners LLP, Valliance Asset Management Ltd, BFAM Partners (Cayman) Ltd, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Snow Lake Management LP, JANE STREET GROUP, LLC, Finepoint Capital LP, Ionic Capital Management LLC, Bracebridge Capital, LLC, and COWEN AND COMPANY, LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.